Notable Call Buying Activity in Teva Pharma (TEVA) Continues -Susquehanna
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $38.98 -0.54%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
EPS Growth %: -11.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
EPS Growth %: -11.5%
Join SI Premium – FREE
Susquehanna options strategist Alison Edwards notes continued buying activity Teva Pharma (NYSE: TEVA) , as an opening investor bought 15k Jan 15 Calls, most for $1.10, creating ~750k shares to buy.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva shares Phase 3 data on once-monthly schizophrenia injection
- Jackson Financial Inc. (JXN) Mentioned as Short at Bear Cave
- Alibaba (BABA) call put ratio 2.4 calls to 1 put as share price up 3% into President Donald Trump and Chinese President Xi Jinping's summit
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
